E-LIB Suche - Ergebnisse für: de Man, Femke M

1

Phase I study of intraperitoneal irinotecan combined with p..:

van Eerden, Ruben A G ; de Boer, Nadine L ; van Kooten, Job P...
British Journal of Surgery. , 2023

2

Intraperitoneal irinotecan combined with systemic chemother..:

van Eerden, Ruben A.G. ; Van De Vlasakker, Vincent ; Guchelaar, Niels A.D....
European Journal of Surgical Oncology. 49 (2023) 2 - p. e200 , 2023

Link: https://doi.org/10.1016/..

3

Dihydropyrimidine Dehydrogenase Phenotyping Using Pretreatm..:

de With, Mirjam ; Knikman, Jonathan ; de Man, Femke M....
Clinical Pharmacology & Therapeutics. 112 (2022) 1 - p. 62-68 , 2022

Link: https://doi.org/10.1002/..

4

UGT1A1 genotype-guided dosing of irinotecan: A prospective ..:

Hulshof, Emma C. ; de With, Mirjam ; de Man, Femke M....
European Journal of Cancer. 162 (2022) - p. 148-157 , 2022

Link: https://doi.org/10.1016/..

5

Tissue Type Differences in ABCB1 Expression and Paclitaxel ..:

van Eerden, Ruben A. G. ; van Doorn, Leni ; de Man, Femke M....
Frontiers in Pharmacology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

6

Effect of the Proton Pump Inhibitor Esomeprazole on the Sys..:

van Doorn, Leni ; Heersche, Niels ; de Man, Femke M....
Clinical Pharmacology & Therapeutics. 111 (2021) 2 - p. 455-460 , 2021

Link: https://doi.org/10.1002/..

7

Effects of Protein and Calorie Restriction on the Metabolis..:

de Man, Femke M. ; van Eerden, Ruben A.G. ; van Doorn, Gerdien M....
Clinical Pharmacology & Therapeutics. 109 (2020) 5 - p. 1304-1313 , 2020

Link: https://doi.org/10.1002/..

8

Association between Paclitaxel Clearance and Tumor Response..:

Toxopeus, Eelke L.A. ; de Man, Femke M. ; Krak, Nanda...
Cancers. 11 (2019) 2 - p. 173 , 2019

Link: https://doi.org/10.3390/..

9

A cost analysis of upfront DPYD genotype–guided dose indivi..:

Henricks, Linda M. ; Lunenburg, Carin A.T.C. ; de Man, Femke M....
European Journal of Cancer. 107 (2019) - p. 60-67 , 2019

Link: https://doi.org/10.1016/..

10

Influence of the Proton Pump Inhibitor Esomeprazole on the ..:

de Man, Femke M. ; Hussaarts, Koen G.A.M. ; de With, Mirjam...
Clinical Pharmacology & Therapeutics. 105 (2019) 6 - p. 1456-1461 , 2019

Link: https://doi.org/10.1002/..

11

Comparison of toxicity and effectiveness between fixed-dose..:

de Man, Femke M. ; Veerman, G.D. Marijn ; Oomen-de Hoop, Esther...
Therapeutic Advances in Medical Oncology. 11 (2019) - p. 175883591983896 , 2019

Link: https://doi.org/10.1177/..

12

Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel ..:

de Man, Femke M. ; van Eerden, Ruben A.G. ; Oomen-de Hoop, Esther...
Cancers. 11 (2019) 6 - p. 826 , 2019

Link: https://doi.org/10.3390/..

13

DPYD genotype-guided dose individualisation of fluoropyrimi..:

Henricks, Linda M ; Lunenburg, Carin A T C ; de Man, Femke M...
The Lancet Oncology. 19 (2018) 11 - p. 1459-1467 , 2018

Link: https://doi.org/10.1016/..

14

Individualization of Irinotecan Treatment: A Review of Phar..:

de Man, Femke M. ; Goey, Andrew K. L. ; van Schaik, Ron H. N...
Clinical Pharmacokinetics. 57 (2018) 10 - p. 1229-1254 , 2018

Link: https://doi.org/10.1007/..

15

Prospective Analysis in GIST Patients on the Role of Alpha-..:

Bins, Sander ; Eechoute, Karel ; Kloth, Jacqueline S. L....
Clinical Pharmacokinetics. 56 (2016) 3 - p. 305-310 , 2016

Link: https://doi.org/10.1007/..